Embody vs Directmeds: Low-cost compounded GLP-1 options compared
Embody vs Directmeds: if your priority is lowest ongoing price, Embody offers compounded semaglutide at $69/month and tirzepatide at $119/month while Direct Meds advertises a promotional start at $147 and lists standard FAQ prices higher. Early verdict: Embody is the lower-price, no-frills option; Direct Meds emphasizes multiple formats and transparent standard pricing.
Compare Embody pricing and delivery
How Embody and Direct Meds differ at a glance
Both providers sell compounded semaglutide and tirzepatide via telehealth and both state that compounded medications are not FDA-approved. Key differences are entry price, formulation options, shipping promises, availability notes, and refund or approval policies. The sections below compare these points directly using only the supplied facts.
1. Price and promotional framing
Embody presents semaglutide at $69/month, marked down from $299, and tirzepatide at $119/month. The provider advertises flat locked in monthly pricing, with the $69 semaglutide price noted as a limited-time offer that may increase. Direct Meds advertises a promotional starting price of $147 and lists standard FAQ pricing of $297/month for semaglutide and $399/month for tirzepatide. Direct Meds also notes a summer promotion saves $150. Final pricing with both providers may depend on clinician recommendations or specific plans where stated.
See Direct Meds current promotion and FAQ prices
2. Formulation and pharmacy details
Embody focuses on compounded semaglutide and compounded tirzepatide injections; its materials emphasize compounded products rather than branded options. Direct Meds offers compounded semaglutide and tirzepatide in injectable and sublingual formats and states medications are provided from U.S.-based 503A compounding pharmacies. Both providers clarify that the compounded medications are not FDA-approved finished products.
Review Embody compounded options
3. Shipping and delivery commitments
Embody promises free shipping with delivery in 1 to 2 days after clinician approval and describes free fast 1 to 2 day delivery. Direct Meds advertises free temperature-controlled UPS or FedEx delivery generally in 1 to 2 days and calls it free next-day shipping in some places. Both describe fast shipping but Direct Meds notes temperature-controlled shipping and specifies UPS or FedEx.
4. Support, refunds, and availability
Embody includes prescription and telemed visits, licensed provider review handled online, and advertises 24/7 support access for dosing and side-effect questions. Embody also highlights no long-term commitment and cancel anytime. Direct Meds includes clinician review, telehealth visits, supplies and nursing support, and explicitly offers a full refund if a prescription is not approved. Direct Meds notes treatment is not available in Mississippi or Louisiana. Embody does not list state exclusions in the supplied material.
Concise comparison table
| Criteria | Embody | Direct Meds |
|---|---|---|
| Starting price | $69/month semaglutide; $119/month tirzepatide | Promotional start $147; FAQ standard $297/mo semaglutide, $399/mo tirzepatide |
| Formulations | Compounded semaglutide and tirzepatide injections | Compounded injectable and sublingual semaglutide and tirzepatide |
| Shipping | Free shipping, 1–2 day delivery after approval | Free temperature-controlled UPS/FedEx, generally 1–2 day or next-day |
| Refunds and approvals | Licensed provider review; cancel anytime; final pricing may vary by dose | Full refund if a prescription is not approved; month-to-month cancellation |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
5. Best-fit use cases from the facts
Embody is framed for cost-driven patients who want a straightforward, low-entry-price telehealth program with fast delivery and no membership. Direct Meds is presented for patients wanting injectable or sublingual format options, explicit compounding pharmacy details, nursing support, and a clear refund policy for unapproved prescriptions, while noting limited-state availability.
Final take on Embody vs Directmeds
In a direct comparison, Embody is the lower-cost, no-frills choice with $69/month semaglutide and $119/month tirzepatide and fast 1 to 2 day shipping after approval. Direct Meds highlights formulation flexibility, temperature-controlled shipping, and a refund if a prescription is not approved, with promotional starting pricing that differs from its FAQ standard prices. Both clearly disclose that compounded medications are not FDA-approved.
Check Direct Meds formats and policies
Go to Embody to confirm current pricing
Choose Embody if you want the lowest advertised entry price for compounded semaglutide or tirzepatide, quick 1 to 2 day shipping after clinician approval, and a lean telehealth approach without membership add ons. Choose Direct Meds if you need injectable or sublingual options, prefer U.S. 503A compounding pharmacy sourcing and temperature-controlled shipping, or value a stated refund if a prescription is not approved. This comparison uses only the supplied facts and preserves each provider’s stated qualifiers.